Azelnidipine
From Self-sufficiency
File:Azelnidipine.png | |
Systematic (IUPAC) name | |
---|---|
O3-[1-[di(phenyl)methyl]azetidin-3-yl] O5-propan-2-yl 2-amino-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate | |
Clinical data | |
Routes of administration | Oral |
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | 123524-52-7 |
ATC code | none |
PubChem | CID 65948 |
ChemSpider | 59352 |
Chemical data | |
Formula | C33H34N4O6 |
Molar mass | 582.64 g/mol[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
Azelnidipine (INN; marketed under the brand name Calblock) is a dihydropyridine calcium channel blocker. It is sold in Japan by Daiichi-Sankyo pharmaceuticals, Inc. Unlike nicardipine, it has a gradual onset and has a long-lasting hypotensive effect, with little increase in heart rate.[1]
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
- ↑ Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
Categories:
- Pages with script errors
- Pages with broken file links
- Drugs with non-standard legal status
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Articles containing unverified chemical infoboxes
- Calcium channel blockers
- Pyridines
- Carboxylate esters
- Azetidines
- Nitro compounds
- Cardiovascular system drug stubs
- 2Fix